BIOSANTE PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 4163
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 2253
 
  
 
C07K PEPTIDES 2134
 
  
 
C08G MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 1119

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
5904920 Regulation of systemic immune responses utilizing cytokines and antigensJun 07, 95May 18, 99[A61K]
5741899 Chimeric receptors comprising janus kinase for regulating cellular pro liferationJun 07, 95Apr 21, 98[C12N, C07K]
5712149 Chimeric receptor molecules for delivery of co-stimulatory signalsFeb 03, 95Jan 27, 98[C12N, C07K]
5637483 Irradiated tumor cell vaccine engineered to express GM-CSFJun 23, 94Jun 10, 97[A61K, C12N]
5480959 Substantially pure bisphenols and polymers comprising bisphenolsApr 11, 94Jan 02, 96[C08G]
5460959 Transduced fibroblastsJun 01, 93Oct 24, 95[C12N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2011/0065,779 AAV VECTOR COMPOSITIONS AND METHODS FOR ENHANCED EXPRESSION OF IMMUNOGLOBULINS USING THE SAMEAbandonedMar 05, 10Mar 17, 11[A61K, C12P, C12N, A61P, C07K]
2010/0317,096 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage siteAbandonedOct 26, 07Dec 16, 10[C07H, C12N]
7714119 AAV vector compositions and methods for enhanced expression of immunoglobulins using the sameExpiredJul 13, 05May 11, 10[C07H, C12N]
7709224 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage siteExpiredApr 26, 04May 04, 10[C12P, C12N]
7662623 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage siteExpiredOct 26, 07Feb 16, 10[C12P, C12N]
7632509 Methods to express recombinant proteins from lentiviral vectorsExpiredJul 18, 06Dec 15, 09[A61K, C12N, C07K]
2009/0270,485 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage siteAbandonedJul 24, 08Oct 29, 09[A61K, C12N]
7498024 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage siteExpiredApr 26, 04Mar 03, 09[C12P, C12N]
7485291 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereofExpiredJun 03, 03Feb 03, 09[C12P, C12N]
2009/0028,857 PD-1 ANTIBODIES IN COMBINATION WITH A CYTOKINE-SECRETING CELL AND METHODS OF USE THEREOFAbandonedJul 23, 08Jan 29, 09[A61K, A61P]
7186699 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genesExpiredMay 28, 04Mar 06, 07[A61K]
2006/0292,682 Addition of transgenes into adenoviral vectorsAbandonedJul 15, 05Dec 28, 06[C12N]
2006/0251,683 Directly injectable formulations which provide enhanced cryoprotection of cell productsAbandonedJul 12, 06Nov 09, 06[A61K, A01N, C12N]
2006/0188,479 Adenovirus vectors containing cell status-specific response elements and methods of use thereofAbandonedAug 18, 05Aug 24, 06[A61K, C12N]
2005/0002,916 Cytokine-expressing cellular vaccine combinationsAbandonedMar 24, 04Jan 06, 05[A61K]
2004/0197,312 Cytokine-expressing cellular vaccine combinationsAbandonedApr 02, 03Oct 07, 04[A61K]
2003/0185,892 Intraocular delivery compositions and methodsAbandonedNov 27, 02Oct 02, 03[A61K]
6077947 DNA encoding an intracellular chimeric receptor comprising Janus kinaseExpiredJun 07, 95Jun 20, 00[C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.